These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24504857)

  • 21. Radioactive seeds for prostate cancer.
    Zietman A
    Health News; 1998 Oct; 4(13):4-5. PubMed ID: 9803172
    [No Abstract]   [Full Text] [Related]  

  • 22. Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.
    Mitch MG; Zimmerman BE; Lamperti PJ; Seltzer SM; Coursey BM
    Med Phys; 2000 Oct; 27(10):2293-6. PubMed ID: 11099196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioactive "seed" implants may rival surgery for low-risk prostate cancer patients.
    Hede K
    J Natl Cancer Inst; 2007 Oct; 99(20):1507-9. PubMed ID: 17925531
    [No Abstract]   [Full Text] [Related]  

  • 24. Seed fixity in the prostate/periprostatic region following brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P; Battista J; Van Dyk J
    Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate brachytherapy. An overview.
    Porter AT; Forman JD
    Cancer; 1993 Feb; 71(3 Suppl):953-8. PubMed ID: 8428345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of radioactive seed embolization to the lung following prostate brachytherapy.
    Tapen EM; Blasko JC; Grimm PD; Ragde H; Luse R; Clifford S; Sylvester J; Griffin TW
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1063-7. PubMed ID: 9869230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.
    Zauls AJ; Ashenafi MS; Onicescu G; Clarke HS; Marshall DT
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1010-6. PubMed ID: 20888132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.
    Heysek RV; Gwede CK; Torres-Roca J; Cantor A; Kelley S; Saini AS; Pow-Sang J
    Brachytherapy; 2006; 5(4):244-50. PubMed ID: 17118318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative ultrasound-fluoroscopy fusion can enhance prostate brachytherapy quality.
    Orio PF; Tutar IB; Narayanan S; Arthurs S; Cho PS; Kim Y; Merrick G; Wallner KE
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):302-7. PubMed ID: 17707285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.
    Blanchard P; Pugh TJ; Swanson DA; Mahmood U; Chen HC; Wang X; Graber WJ; Kudchadker RJ; Bruno T; Feeley T; Frank SJ
    Brachytherapy; 2018; 17(2):265-276. PubMed ID: 29269207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calculating prescription doses for new sources by biologically effective dose matching.
    Pritz J; Forster KM; Saini AS; Biagioli MC; Zhang GG
    Brachytherapy; 2012; 11(6):521-7. PubMed ID: 22436519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An automated, fast and accurate registration method to link stranded seeds in permanent prostate implants.
    Westendorp H; Nuver TT; Moerland MA; Minken AW
    Phys Med Biol; 2015 Oct; 60(20):N391-403. PubMed ID: 26439900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
    Lee J; Mian OY; Le Y; Bae HJ; Burdette EC; DeWeese TL; Prince JL; Song DY
    Radiother Oncol; 2017 Jul; 124(1):61-67. PubMed ID: 28647400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry.
    Westendorp H; Hoekstra CJ; van't Riet A; Minken AW; Immerzeel JJ
    Brachytherapy; 2007; 6(4):231-7. PubMed ID: 17991620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nomograph for permanent implants of palladium-103 seeds.
    Anderson LL; Moni JV; Harrison LB
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):129-35. PubMed ID: 8365933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma.
    Walsh P
    J Urol; 2001 Oct; 166(4):1581-2. PubMed ID: 11569476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.